Seagen Inc. announced Marc E. Lippman, M.D. will not stand for re-election as a director of the company at the company's 2022 annual meeting of stockholders and will resign as a director of the company effective upon the conclusion of the 2022 annual meeting. Dr. Lippman will continue to serve as a director of the company until the 2022 annual meeting. In his notice to the company with respect to his decision not to stand for re-election and to resign from the board effective upon the conclusion of the 2022 annual meeting, Dr. Lippman indicated that his decision was not the result of any disagreement with the company, its management, or its board of directors.